Stavanger University Hospital Inflammatory Bowel Disease Trial (SUSI)
The study aims at studying the outcomes of a protocol-based handling of newly diagnosed Inflammatory bowel disease ( IBD ) patients within a defined uptake area in Norway. It is a descriptive study and no hypothesis is predefined.
Cytokine studies, QoL and fatigue assessment will be included for hypothesis-generating purposes.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Management of Inflammatory Bowel Disease in the Stavanger Area - a Prospective Evaluation of Standardized Treatment Regimens on Disease Outcome With Focus on Mucosal Healing and Associations to Fatigue|
- Clinical efficacy of IBD drug therapy [ Time Frame: 5 years ]Endoscopic, clinical and biochemical response
- Fatigue in patients with coeliac disease - substudy [ Time Frame: 1 year ]Fatigue at diagnosis and after one year of gluten free diet
- Fatigue in IBD [ Time Frame: 5 years ]Fatigue at diagnosis and during follow-up
Biospecimen Retention: Samples With DNA
|Study Start Date:||April 2012|
|Estimated Study Completion Date:||December 2018|
|Estimated Primary Completion Date:||December 2017 (Final data collection date for primary outcome measure)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT01551563
|Contact: Tore B Grimstad, MD PhD +47909 21 650|
|Principal Investigator:||lars Aabakken||prof of medicine UIO|